Roche's Virtual Pipeline Event
Agenda:
Ophthalmology overview
BOULEVARD: Phase 2 results of the bispecific VEGF/Ang2 antibody RG7716 in diabetic macula edema
Jason Ehrlich, M.D. Ph.D., Senior Group Medical Director, Ophthalmology
Sascha Fauser, M.D., Head pRED Ophthalmology

Please register to access the replay*

*Privacy notice

Phase 2 results of the bispecific VEGF/Ang2 antibody RG7716 in diabetic macula edema presented at Angiogenesis 2018

Investors
Past IR Events
View more Events

Downloads

Related links